ARTICLE | Company News
Washington University School of Medicine in St. Louis, Denali Therapeutics deal
September 5, 2016 7:00 AM UTC
Denali partnered with Washington University School of Medicine to develop and commercialize antibodies targeting apolipoprotein E (APOE), a genetic risk factor for Alzheimer’s disease (AD). Washingto...